MRD Testing Platforms in Colorectal Cancer

Opinion
Video

Colorectal cancer specialists discuss MRD testing platforms and how to choose among the available testing assays.

Related Videos
A panel of 5 experts on lung cancer
A panel of 5 experts on lung cancer
Amin Nassar, MD
Video 18 - "Reflecting on Differentiated Thyroid Cancer: Final Insights"
Video 17 - "Phase 2 ATLEP Trial Results"
Pashtoon Murtaza Kasi, MD, MS
A panel of 5 experts on lung cancer
A panel of 5 experts on lung cancer
Katrina S. Pedersen, MD, MS, associate professor, John T. Milliken Department of Medicine, Division of Oncology, Medical Oncology program leader, cofounder, Young Onset Colorectal Cancer Program, Washington University School of Medicine in St. Louis, Siteman Cancer Center
Video 16 - "Neoadjuvant Approach in RAI-R-DTC"
Related Content
Sarah ES Leary, MD, MS, of Fred Hutchinson

Tovorafenib Offers an Efficacious Option for R/R BRAF-Positive Pediatric Low-Grade Glioma

May 28th 2024
Article
Stephen Liu, MD; Sara A. Hurvitz, MD, FACP; S. Vincent Rajkumar, MD; Sumanta Kumar Pal, MD, FASCO; Shubham Pant, MD, MBBS

Oncology Experts Preview Top Abstracts From the 2024 ASCO Annual Meeting

May 23rd 2024
Podcast
Petros Grivas, MD, PhD, physician, Seattle Cancer Care Allliance; associate professor, Department of Medicine, Division of Oncology, clinical director, Genitourinary Cancers Program, University of Washington School of Medicine; associate member, Clinical Research Division, Fred Hutchinson Cancer Center

Advances With Erdafitinib Exemplify the Push For Precision Medicine in Urothelial Cancer

May 23rd 2024
Article
Matthew Lunning, DO, FACP, associate professor, Division of Oncology & Hematology, associate vice chair, research, Department of Internal Medicine, assistant vice chancellor, clinical research, University of Nebraska Medical Center; Sarah Rutherford, MD, assistant professor, medicine, Division of Hematology/Oncology, Weill Cornell Medicine

Lunning and Rutherford Detail Considerations for BV-AVD Use in Older Patients With Hodgkin Lymphoma

April 18th 2024
Podcast
Robert C. Garrett, FACHE, CEO, Hackensack Meridian Health

Georgetown’s Cancer Center Awarded Top Designation by National Cancer Institute; Comprehensive Cancer Center Consortium Includes Hackensack Meridian’s John Theurer Cancer Center

May 15th 2024
Article
Michael B. Atkins, MD, deputy director, Georgetown Lombardi Comprehensive Cancer Center

Salvage Nivolumab/Ipilimumab Following Nivolumab Affords Treatment-Free Survival in RCC

May 11th 2024
Article